PCI Biotech Holding ASA Tangible Net Worth Ratio
PCI Biotech Holding ASA tangible net worth ratio. PCI Biotech Holding ASA (PCIB) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (Nkr0.00) from net assets (Nkr12.52 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check how strategically is PCI Biotech Holding ASA's equity deployed to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of PCI Biotech Holding ASA (2008–2024)
Tangible net worth ratio of PCI Biotech Holding ASA from 2008 to 2024. This chart shows how PCI Biotech Holding ASA's Tangible Net Worth Ratio has changed across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of Nkr12.52 Million with intangible assets of Nkr0.00 NOK. See PCI Biotech Holding ASA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
PCI Biotech Holding ASA Tangible Net Worth Ratio by Year (2008–2024)
PCI Biotech Holding ASA tangible net worth ratio by year from 2008 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for PCI Biotech Holding ASA from 2008 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see PCI Biotech Holding ASA (PCIB) total market value.
| Year | Tangible NW Ratio | Net Assets (NOK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | Nkr23.45 Million | Nkr0.00 | Nkr31.21 Million | ▲ +0.0 pp |
| 2023 | 100.0% | Nkr39.04 Million | Nkr0.00 | Nkr44.05 Million | ▲ +0.0 pp |
| 2022 | 100.0% | Nkr57.40 Million | Nkr0.00 | Nkr63.48 Million | ▲ +0.0 pp |
| 2021 | 100.0% | Nkr113.79 Million | Nkr0.00 | Nkr135.98 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Nkr189.24 Million | Nkr0.00 | Nkr209.12 Million | ▲ +0.0 pp |
| 2019 | 100.0% | Nkr254.83 Million | Nkr0.00 | Nkr282.03 Million | ▲ +0.0 pp |
| 2018 | 100.0% | Nkr339.95 Million | Nkr0.00 | Nkr357.06 Million | ▲ +0.0 pp |
| 2017 | 100.0% | Nkr41.84 Million | Nkr0.00 | Nkr58.44 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Nkr13.09 Million | Nkr0.00 | Nkr22.40 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Nkr44.28 Million | Nkr0.00 | Nkr56.40 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Nkr9.11 Million | Nkr0.00 | Nkr20.38 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Nkr43.40 Million | Nkr0.00 | Nkr52.74 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Nkr69.71 Million | Nkr0.00 | Nkr78.20 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Nkr92.53 Million | Nkr0.00 | Nkr100.17 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Nkr105.42 Million | Nkr0.00 | Nkr114.54 Million | ▲ +0.1 pp |
| 2009 | 99.9% | Nkr35.08 Million | Nkr27.00K | Nkr41.53 Million | ▲ +0.1 pp |
| 2008 | 99.8% | Nkr49.30 Million | Nkr76.00K | Nkr54.58 Million | — |